摘要
目的观察硫糖铝联合法莫替丁对急性胃炎患者的治疗效果。方法从我院消化内科接诊的急性胃炎患者中抽取120例,分为观察组与对照组,观察组使用硫糖铝与法莫替丁联合治疗,对照组只单纯使用法莫替丁治疗。对比观察两组患者的治疗效果。结果观察组患者的有效率(96.67%)明显高于对照组患者(85.00%),差异有统计学意义(/9〈0.05)。结论硫糖铝联合法莫替丁能够对急性胃炎产生理想的治疗效果,且比单独使用法莫替丁更为有效,具有在临床中进一步推广应用的价值。
Objective To observe the efficacy of sucralfate combined with famotidine for acute gastritis in patients. Methods 120 patients with acute gastritis who had visited our department of digestive diseases were divided into a study group and a control group. The study group received combination therapy with sucralfate and famotidine, whereas the control group received famotidine alone. The efficacy was compared between the two groups. Results The effectiveness rate was obviously higher in the study group than in the control group, with a statistical difference (P〈0.05). Conclusions Sucralfate combined with famotidine has an ideal efficacy in the treatment of acute gastritis and is more effective than famotidine alone. This combination therapy has a value for further clinical popularization and application.
出处
《国际医药卫生导报》
2013年第3期354-356,共3页
International Medicine and Health Guidance News
关键词
硫糖铝
法莫替丁
联合治疗
急性胃炎
Sucralfate
Famotidine
Combination therapy
Acute gastritis